JP Morgan Chase
NVAX icon

JP Morgan Chase’s Novavax NVAX Stock Holding History

JP Morgan Chase’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,200
Closed -$82K – 7778
2025
Q4 		$82K Hold
12,200
– – ﹤0.01% 5990
2025
Q3 		$106K Sell
12,200
-29,000
-70% -$226K ﹤0.01% 5870
2025
Q2 		$260K Hold
41,200
– – ﹤0.01% 5108
2025
Q1 		$264K Buy
+41,200
New +$341K ﹤0.01% 5120
2024
Q4 		– Sell
-21,000
Closed -$265K – 7624
2024
Q3 		$265K Sell
21,000
-30,600
-59% -$395K ﹤0.01% 5278
2024
Q2 		$653K Buy
+51,600
New +$519K ﹤0.01% 4533
2024
Q1 		– Sell
-55,000
Closed -$264K – 7742
2023
Q4 		$264K Sell
55,000
-200,000
-78% -$1.22M ﹤0.01% 5203
2023
Q3 		$1.85M Buy
+255,000
New +$2.04M ﹤0.01% 3594
2023
Q2 		– Sell
-1,130,000
Closed -$7.83M – 7211
2023
Q1 		$7.83M Buy
1,130,000
+399,100
+55% +$3.67M ﹤0.01% 2489
2022
Q4 		$7.51M Sell
730,900
-431,800
-37% -$7.62M ﹤0.01% 2496
2022
Q3 		$21.2M Buy
1,162,700
+605,300
+109% +$26.2M ﹤0.01% 1540
2022
Q2 		$28.7M Sell
557,400
-249,800
-31% -$12.9M ﹤0.01% 1356
2022
Q1 		$59.5M Buy
807,200
+114,500
+17% +$10.2M 0.01% 1080
2021
Q4 		$99.1M Buy
+692,700
New +$119M 0.01% 888
2019
Q2 		– Sell
-25,250
Closed -$278K – 5926
2019
Q1 		$278K Buy
+25,250
New +$797K ﹤0.01% 4478

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase's NVAX Position: Q1 2026 in Review

JP Morgan Chase increased its Novavax (NVAX) stake by 4.1% in Q1 2026, buying an estimated $27.1K and bringing the position to 75,200 shares worth $608K. The position accounts for ﹤0.01% of the portfolio, ranked #4881.

JP Morgan Chase first reported a position in NVAX in Q2 2013 and has held it in 50 quarters since. The position peaked at $83.8M in Q1 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • JP Morgan Chase held 75,200 shares of Novavax worth $608K as of Q1 2026.
  • JP Morgan Chase bought 2,995 Novavax shares in Q1 2026, an estimated $27.1K.
  • Novavax made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4881 holding.
  • JP Morgan Chase first reported a position in Novavax in Q2 2013 and has held it in 50 quarters since.
  • JP Morgan Chase's Novavax position peaked at $83.8M in Q1 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.